Published in Clin Diagn Lab Immunol on March 01, 1997
Recent insights into the biology and biomedical applications of Flock House virus. Cell Mol Life Sci (2008) 1.20
Expression and immunoreactivity of HCV/HBV epitopes. World J Gastroenterol (2005) 0.76
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A (1990) 9.98
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33
Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A (1990) 2.12
The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules. AIDS Res Hum Retroviruses (1993) 1.37
Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 1.18
Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays. J Acquir Immune Defic Syndr (1994) 1.13
DnaK-mediated alterations in human growth hormone protein inclusion bodies. Biotechnology (N Y) (1992) 1.08
Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 1.05
A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J Immunol (1993) 1.02
Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up. J Med Virol (1993) 0.98
Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin Chem (1992) 0.96
Identification of four epitopes in hepatitis C virus core protein. J Clin Microbiol (1993) 0.91
Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. J Med Virol (1994) 0.88
A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies. Vaccine (1995) 0.87
Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system. J Clin Microbiol (1993) 0.87
Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera. Gene (1995) 0.87
Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGPGRAF. Correlation between predicted conformation and antigenicity. FEBS Lett (1994) 0.87
Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein. J Immunol Methods (1996) 0.85
A blocking agent and a blocking step are not needed in ELISA, immunostaining dot-blots and western blots. J Immunol Methods (1989) 0.85
Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen. Hepatology (1992) 0.84
Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodies. J Med Virol (1992) 0.83
Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains. J Gen Virol (1995) 0.83
Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR. Ann Hematol (1994) 0.81
Characterization of antigenic determinants in the core antigen of the hepatitis C virus. Virology (1994) 0.81
IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol (1994) 0.78
Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment. J Clin Microbiol (1994) 0.77
Clinical evaluation of the antibody against core protein of hepatitis C virus. Gastroenterol Jpn (1993) 0.77
The structure and evolution of the human beta-globin gene family. Cell (1980) 21.24
Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J (1985) 5.47
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J (2001) 5.23
Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem (2001) 4.87
The primary structure of the human epsilon-globin gene. Cell (1980) 3.88
Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell (1999) 3.33
Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci U S A (1997) 3.26
Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res (1984) 3.12
Complete nucleotide sequence of the 5' noncoding region of rabbit beta-globin mRNA. Cell (1977) 3.01
Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J (1984) 2.88
A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res (1994) 2.80
AUG is the only recognisable signal sequence in the 5' non-coding regions of eukaryotic mRNA. Nature (1978) 2.76
A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res (1987) 2.39
Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J (1987) 2.31
The 5' flanking region of human epsilon-globin gene. Nucleic Acids Res (1980) 2.30
DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet (1983) 2.28
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther (2010) 2.13
Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Natl Acad Sci U S A (1983) 2.10
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum Mutat (2009) 2.05
Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest (1998) 2.02
Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J Biol Chem (2000) 2.00
Expression of a human alpha-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J (1984) 1.83
Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A (1994) 1.81
New insights into form and function of fibronectin splice variants. J Pathol (2008) 1.80
Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest (1985) 1.73
Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res (1998) 1.72
Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol Cell Biol (1999) 1.69
Gene structure of human apolipoprotein A1. Nucleic Acids Res (1983) 1.58
Molecular cloning of human epsilon-globin gene. Proc Natl Acad Sci U S A (1979) 1.56
Organization of the human transferrin gene: direct evidence that it originated by gene duplication. Proc Natl Acad Sci U S A (1985) 1.53
Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet (1999) 1.50
Identification of Acinetobacter isolates in the A. calcoaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic-spacer sequences. J Clin Microbiol (1995) 1.45
Selective in vitro transcription of one of the two Alu family repeats present in the 5' flanking region of the human epsilon-globin gene. Nucleic Acids Res (1981) 1.41
Isolation of a Xenopus laevis alpha-globin gene. J Mol Biol (1981) 1.39
Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: a genotype-phenotype correlation study. Br J Dermatol (2014) 1.39
Structure-function relationship of 5' non-coding sequence of rabbit alpha- and beta-globin mRNA. Nature (1977) 1.39
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance. Nucleic Acids Res (1984) 1.38
Isolation of the human HDL apoprotein A1 gene. Nucleic Acids Res (1982) 1.36
The Alu family repeat promoter has a tRNA-like bipartite structure. EMBO J (1983) 1.36
Typing of Staphylococcus aureus by amplification of the 16S-23S rRNA intergenic spacer sequences. FEMS Microbiol Lett (1994) 1.31
Cell type specific trans-acting factors are involved in alternative splicing of human fibronectin pre-mRNA. EMBO J (1989) 1.27
Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol (1991) 1.27
Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli. FEBS Lett (1987) 1.24
Directed semisynthetic point mutational analysis of an RNA polymerase III promoter. Nucleic Acids Res (1983) 1.23
Influence of correct secondary and tertiary RNA folding on the binding of cellular factors to the HCV IRES. Nucleic Acids Res (2000) 1.23
Porcine rotaviruses antigenically related to human rotavirus serotypes 1 and 2. J Clin Microbiol (1990) 1.17
Identification of a mutation that perturbs NF1 agene splicing using genomic DNA samples and a minigene assay. J Med Genet (2003) 1.15
Serological characterization of bovine rotaviruses isolated from dairy and beef herds in Argentina. J Clin Microbiol (1989) 1.14
Regulation of the fibronectin EDA exon alternative splicing. Cooperative role of the exonic enhancer element and the 5' splicing site. FEBS Lett (1998) 1.13
Antigenic characterization of swine rotaviruses in Argentina. J Clin Microbiol (1989) 1.13
In vivo translational efficiency of different hepatitis C virus 5'-UTRs. FEBS Lett (1997) 1.12
Factors in the cycle of violence: gender rigidity and emotional constriction. J Trauma Stress (1996) 1.11
Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol (1994) 1.11
Deletion analysis of a unique 3' splice site indicates that alternating guanine and thymine residues represent an efficient splicing signal. Nucleic Acids Res (1987) 1.11
Molecular cloning of human LDL apolipoprotein B cDNA. Evidence for more than one gene per haploid genome. Atherosclerosis (1985) 1.10
Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood (2000) 1.09
Fibronectin, the generation of multiple polypeptides from a single gene. Oxf Surv Eukaryot Genes (1986) 1.08
The relationship between gastric mucosal changes and nitrate intake via drinking water in a high-risk population for gastric cancer in Moping county, China. Eur J Cancer Prev (1992) 1.08
Isolation of group A swine rotaviruses displaying atypical electropherotypes. J Clin Microbiol (1987) 1.06
Mutational analysis of the different bulge regions of hepatitis C virus domain II and their influence on internal ribosome entry site translational ability. J Biol Chem (2001) 1.06
PCR ribotyping for characterizing Salmonella isolates of different serotypes. J Clin Microbiol (1996) 1.06
Nucleotide sequence analysis of Triatoma virus shows that it is a member of a novel group of insect RNA viruses. J Gen Virol (2000) 1.06
Triatoma virus pathogenicity in laboratory colonies of Triatoma infestans (Hemiptera:Reduviidae). J Med Entomol (1997) 1.05
The compatibility of Hly factor, a transmissible element which controls alpha-haemolysin production in Escherichia coli. J Gen Microbiol (1975) 1.04
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience (2006) 1.02
Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains. Virology (1990) 1.02
Comparison of the human apolipoprotein genes. Apo AII presents a unique functional intron-exon junction. J Mol Biol (1985) 1.02
Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease? Exp Neurol (2001) 1.00
Ribonuclease activities associated with purified foot and mouth disease virus. Arch Virol (1978) 0.99
Heterogeneity of the polyribocytidylic acid tract in aphthovirus: biochemical and biological studies of viruses carrying polyribocytidylic acid tracts of different lengths. J Virol (1984) 0.99
Expression of the plasmid pKM101--determined DNA repair system in recA- and lex- strains of Escherichia coli. Mol Gen Genet (1976) 0.99
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. Eur J Epidemiol (1987) 0.98
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J Lipid Res (1998) 0.98
Incidence of group A and atypical rotaviruses in Brazilian pig herds. Res Vet Sci (1986) 0.97
Characterization of antimicrobial resistance and class 1 integrons in Enterobacteriaceae isolated from Mediterranean herring gulls (Larus cachinnans). Microb Drug Resist (2008) 0.97
Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res (1990) 0.97
Characterization of genetic markers in the 3' end of the apo B gene and their use in family and population studies. Atherosclerosis (1988) 0.97
Regulation of fibronectin expression in rat regenerating liver. Nucleic Acids Res (1995) 0.95
Small nonoccluded viruses from triatomine bug Triatoma infestans (Hemiptera: Reduviidae). J Invertebr Pathol (1987) 0.95
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 year study. J Clin Virol (2000) 0.94
Donor and acceptor splice signals within an exon of the human fibronectin gene: a new type of differential splicing. FEBS Lett (1986) 0.94
Rearrangement of genomic segment 11 in two swine rotavirus strains. J Gen Virol (1988) 0.94
Restoration of mutability in non-mutable Escherichia coli carrying different plasmids. Mol Gen Genet (1977) 0.93
Incompatibility of R plasmids from clinical material. Zentralbl Bakteriol Orig A (1979) 0.93
Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites. Parasite Immunol (1999) 0.93
Mutagenic activity of diazoacetylglycine derivatives. Antimicrob Agents Chemother (1974) 0.92
Characterization of Triatoma virus, a picorna-like virus isolated from the triatomine bug Triatoma infestans. J Gen Virol (1988) 0.92
Sequence analysis and in vivo expression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events. Nucleic Acids Res (1988) 0.92
Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions. J Clin Microbiol (1996) 0.92
Hypertension in beta-adducin-deficient mice. Hypertension (2000) 0.92
Mapping the collagen-binding site of human fibronectin by expression in Escherichia coli. EMBO J (1986) 0.92
Heterogeneity of the polyribocytidilic acid tract in aphthovirus: changes in the size of the poly(C) of viruses recovered from persistently infected cattle. Virology (1988) 0.91
Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain. Biochem Biophys Res Commun (1991) 0.91
Biochemical characterization of an aphthovirus type 0(1) strain campos attenuated for cattle by serial passages in chicken embryos. Virology (1985) 0.91
Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin Cancer Res (1997) 0.91
Foot and mouth disease virus. II. Endoribonuclease activity within purified virions. Virology (1978) 0.90